Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
Director, 10%+ Owner
-
Stock Symbol
-
FATE on Nasdaq
Redmile Group, LLC - trading volume in the past year for Fate Therapeutics Inc
Holdings reported by Redmile Group, LLC for Fate Therapeutics Inc
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
13.2M |
$57.6M |
$4.37 |
Dec 26, 2023 |
Indirect |
|
|
| Pre-Funded Warrants to Purchase Common Stock |
3.89M |
$21.4M |
$5.50 |
Mar 21, 2024 |
Indirect |
Common Stock |
|
| Stock Option (Right to Buy) |
40K |
$109K |
$2.73 |
Jun 7, 2024 |
Indirect |
Common Stock |
|
Transactions reported by Redmile Group, LLC for Fate Therapeutics Inc
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.